The Omiljung variant strain has now spread in 77 countries and territories around the world, and WHO says that Omiqueron is spreading at an unprecedented rate. At present, the harm is underestimated, and although the symptoms of infection with the Omikejong variant are less severe, a large number of cases of infection can overwhelm the health system.
In the early days of the mutant strain, Omiljung, South African experts said the patients were only "mildly coughing and couldn't understand why the world was so nervous." However, after the study and analysis of relevant medical experts, it was found that this is a more transmissible new crown variant strain that avoids the human defense system.
Israel and Japan were the first to respond by closing all entry lanes for foreigners and beginning to lock the country's doors against virus invasion. As the virus continues to spread, various transmission phenomena have occurred around the world today, and the speed is far beyond the previous common and delta strains.
In this regard, at the "2021 Greater Bay Area (Shenzhen) Vaccine Summit", Academician Zhong Nanshan made a special evaluation of the new coronavirus Amickon variant, and Zhong Nanshan emphasized two points: "I don't think it is necessary to adjust immediately. "I'm sure it won't be completely ineffective for Aumikoron." This is Zhong Nanshan's trust in China's vaccines.
Although it is said that Omicron was first discovered in South Africa. But the same strain was discovered in the United States as early as 5 months ago, and there are currently 33 states in the United States that have spread the Omicron.
Did our vaccine go blank?
In fact, this is not, according to the explanation of Academician Zhong Nanshan, although the inactivated vaccine will be slightly lower, but in the scope of protection, it is indeed the most extensive, and Aomi Kerong also belongs to a new crown mutation, which will also have a protective effect. In the case of vaccination of booster needles, a third dose has been shown to have enhanced clinical protection.
After receiving two doses of inactivated vaccine, the mRNA vaccine, subunit protein vaccine, and adenovirus vector vaccine were all effective. On a global issue, "if its pathogenicity rate is not as terrible as we say," then it is likely to become a new influenza in the future. It's like a cold.
Whether it is necessary to replace the strain for the development and vaccination of related vaccines, Zhong Nanshan said: "I don't think it is necessary to adjust immediately. "Perhaps in the future, masks will become a must-have for going out, and each country or region will do a good job in epidemic prevention and protection to a large extent to avoid the spread of infection."
Some of the information reference source: The Paper